Nitric oxide synthase as a therapeutic target in sepsis-More questions than answers?
- 1 September 1998
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Critical Care Medicine
- Vol. 26 (9), 1469-1470
- https://doi.org/10.1097/00003246-199809000-00001
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- NG-monomethyl-L-arginine improves survival in a pig model of abdominal sepsisCritical Care Medicine, 1998
- Response of the septic vasculature to prolonged vasopressor therapy with N (omega-monomethyl-L-arginine) and epinephrine in caninesCritical Care Medicine, 1998
- Anti-inflammatory therapies to treat sepsis and septic shockCritical Care Medicine, 1997
- Nitric oxide and shockDisease-a-Month, 1997
- Increased serum nitrite and nitrate concentrations in children with the sepsis syndromeCritical Care Medicine, 1995
- Nitric oxide regulates renal hemodynamics and urinary sodium excretion in dogs.Hypertension, 1994
- LACK OF PROTECTION BY Nw-METHYL-L-ARGININE (NMA), A NITRIC OXIDE SYNTHASE INHIBITOR, IN ENDOTOXIN (LPS)-CHALLENGED CANINESCritical Care Medicine, 1993
- N omega-amino-L-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin.The Journal of Experimental Medicine, 1992
- Double-edged role of endogenous nitric oxideThe Lancet, 1992